BZH Holds Up Better Than Peers as Shorts Quietly Retreat

The lending market tells a story of shorts in retreat, not advance. Short interest has fallen roughly 17.6% over the past month, dropping from around 2.93 million shares to 2.33 million. The week-on-week move was a further 3.3% reduction. Cost to borrow is exceptionally low at 0.56% — a rate that has actually drifted down from 0.70% in early June, signalling no meaningful demand pressure in the lending market. Availability is ample at 502%, meaning there are roughly five shares available to borrow for every one currently lent out. That is well above the 52-week tightest level of 312%. The ORTEX short score has also eased from 60.1 a week ago to 54.3 today — still above the midpoint of its range, but moving in the right direction for bulls.

Options positioning reinforces the less defensive tone. The put/call ratio is running at 0.43, meaningfully below its 20-day average of 0.52 and close to its 52-week low of 0.35. That is nearly one standard deviation below the norm — options traders are leaning bullish, or at least not reaching for protection. The contrast with the broader sector sell-off is striking: while peers declined sharply, BZH's options market saw no surge in put demand.

The Street picture is mixed, and the analyst data carries some staleness worth flagging. The most recent analyst action on record dates to August 2025, when Oppenheimer trimmed its target to $30 while maintaining an Outperform rating. Prior to that, Wedbush had a $41 target (also stale at over a year old). The consensus mean target of $25 sits below the current price of $27.42, which may reflect how far the stock has moved since those targets were set rather than genuine downside conviction — treat those numbers with caution. The bull case centres on BZH's push into zero-energy-ready homes improving gross margins in H2 of the fiscal year, alongside a stated goal of double-digit book value per share CAGR through FY2027. The bear case is harder to dismiss: orders fell 16% year-over-year in Q2, and margin forecasts have been cut twice. Price-to-book is 0.59, and the EV/EBITDA multiple has contracted by roughly 1.2 turns over the past 30 days — the market is not re-rating this as a growth story yet. EPS momentum over 30 days ranks at the 100th percentile, but the 90-day reading sits at just the 1st percentile, underlining how uneven the recent trend has been. The short score rank of 15th percentile is notable — it suggests the short-side positioning in BZH is actually less extreme than most of its sector peers.

Institutional ownership is concentrated and mostly stable. Donald Smith & Co. holds 11.3% and was a modest seller in Q1. BlackRock edged up its position to 10.9% as of June 30. State Street added around 97,000 shares in the same period, a smaller but positive signal. CEO Allan Merrill remains a significant holder with 5.2% of shares, though insider trading data is stale — the most recent filings are from November 2025, when Merrill and CFO David Goldberg both sold modest amounts at prices well below today's level, making that activity more a reflection of where the stock was than where it is.

Earnings on July 30 will determine whether the relative resilience of the past week was justified. The last print — Q2 FY2026 on April 30 — saw the stock fall 2.6% the next day and 12% over the following five sessions, so the market has punished disappointing updates sharply. The focus then will be on whether order trends have stabilised from Q2's 16% decline, and whether the margin guidance for H2 is holding or being trimmed further.